Reduction in medication costs for patients with chronic nonmalignant pain completing a pain rehabilitation program: A prospective analysis of admission, discharge, and 6-month follow-up medication costs

Pain Medicine

Volumn 10, Issue 5, 2009, Pages 787-796

  Cunningham, Julie L ^a   Rome, Jeffrey D ^a   Kerkvliet, Jennifer L ^a   Townsend, Cynthia O ^a  

^a Mayo Clinic   (United States)

Author keywords

Chronic pain; Cost; Medication; Pain rehabilitation; Pharmacist

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIMIGRAINE AGENT; BENZODIAZEPINE DERIVATIVE; CENTRAL STIMULANT AGENT; MORPHINE; MUSCLE RELAXANT AGENT; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

ADULT; ARTICLE; CHRONIC NONMALIGNANT PAIN; CHRONIC PAIN; CLINICAL TRIAL; COGNITIVE BEHAVIORAL STRESS MANAGEMENT; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DAILY LIFE ACTIVITY; DRUG COST; FEEDBACK SYSTEM; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH EDUCATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTERVIEW; LEISURE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL THERAPY; PAIN ASSESSMENT; PRESCRIPTION; QUESTIONNAIRE; REHABILITATION CARE; RISK REDUCTION; TREATMENT DURATION;

ACTIVITIES OF DAILY LIVING; ADMINISTRATION, CUTANEOUS; ADULT; COHORT STUDIES; COST SAVINGS; COSTS AND COST ANALYSIS; DRUG COSTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PATIENT ADMISSION; PATIENT DISCHARGE; PRESCRIPTION DRUGS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 68349148228     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2009.00582.x     Document Type: Article

References (44)

1. National Pharmaceutical Council and Joint Commission on Accreditation of Healthcare Organizations. Pain: Current Understanding of Assessment, Management and Treatments. Oakbrook Terrrace, IL: Joint Commission On Accreditation Of Healthcare Organizations; 2001.
2. Turk D. Clinicians' attitudes about prolonged use of opioids and the issue of patient heterogeneity. J Pain Symptom Manage 1996;11:218-30.
3. Robinson RL, Birnbaum HG, Morley MA, et al. Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheumatol 2003;30:1318-25.
4. White KP, Speechley M, Harth M, Ostbye T. The London fibromyalgia epidemiology study: Direct health care costs of fibromyalgia syndrome in London, Canada. J Rheumatol 1999;26:885-9.
5. Olsen Y, Daumit GL, Ford DE. Opioid prescriptions by U.S. primary care physicians from 1992 to 2001. J Pain 2006;7:225-35.
6. Watkins E, Wollan PC, Melton LJ, Yawn BP. Silent pain sufferers. Mayo Clin Proc 2006;81:167-71.
7. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287-333.
8. Bouckoms AJ, Masand P, Murray GB, et al. Chronic nonmalignant pain treated with long-term oral narcotic analgesics. Ann Clin Psychiatry 1992;4:185-92.
9. Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP. Opioid therapy for chronic noncancer back pain: A randomized prospective study. Spine 1998;23:2591-600.
10. Moulin DE, Iezzi A, Amireh R, et al. Randomised trial of oral morphine for chronic non-cancer pain. Lancet 1996;347:143-7.
11. Schnitzer TJ, Ferraro A, Hunsche E, Kong SX. A comprehensive review of clinical trials on the efficacy and safety of drugs for the treatment of low back pain. J Pain Symptom Manage 2004;28:72-95.
12. Borger C, Smith S, Truffer C, et al. Health Spending Projections through 2015: Changes on the Horizon. Health Affairs 2006; Web Exclusives Supplement 25: W61-73. DOI: 10.1377/hlthaff.25.w61.
13. RxList.com. The Top 200 Prescriptions for 2005 by Number of US Prescriptions Dispensed. Available at: http://www.rxlist.com/top200.htm (accessed December 2006).
14. Mapel DW, Shainline M, Paez K, Gunter M. Hospital, pharmacy, and outpatient costs for osteoarthritis and chronic back pain. J Rheumatol 2004;31:573-83.
15. Vogt MT, Kwoh CK, Cope DK, et al. Analgesic usage for low back pain: Impact on health care costs and service use. Spine 2005;30:1075-81.
16. Straus BN. Chronic pain of spinal origin: The costs of intervention. Spine 2002;27:2614-9.
17. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: Disability and economic costs. Arch Intern Med 1999;159:813-8.
18. Gatchel RJ, Okifuji A. Evidence-based scientific data documenting the treatment and cost-effectiveness of comprehensive pain programs for chronic nonmalignant pain. J Pain 2006;7:779-93.
19. Turk D. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain 2002;18:355-65.
20. Rome JD, Townsend CO, Bruce BK, et al. Chronic noncancer pain rehabilitation with opioid withdrawal: Comparison of treatment outcomes based on opioid use status at admission. Mayo Clin Proc 2004;79:759-68.
21. Tollison CD, Kriegel ML, Downie GR. Chronic low back pain: Results of treatment at the pain therapy center. South Med J 1985;78:1291-5.
22. Townsend CO, Kerkvliet JL, Bruce BK, et al. A longitudinal study of the efficacy of a comprehensive pain rehabilitation program with opioid withdrawal: Comparison of treatment outcomes based on opioid use status at admission. Pain 2008;140:177-89.
23. McCracken LM, Eccleston C. A prospective study of acceptance of pain and patient functioning with chronic pain. Pain 2005;118:164-9.
24. Kerns RD, Turk DC, Rudy TE. The Westhaven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 1985;23:345-56.
25. Berstein IH, Jaremko M, Hinkley BS. On the utility of the West Haven-Yale Multidimensional Pain Inventory. Spine 1995;20:956-63.
26. Deisinger JA, Cassisi JE, Lofland KR, Cole P, Bruehl S. An examination of the psychometric structure of the Multidimensional Pain Inventory. J Clin Psychol 2001;57:765-83.
27. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
28. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Lincoln: QualityMetric Inc.; 2000.
29. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
30. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ. Assessing depressive symptoms in five psychiatric populations: A validation study. Am J Epidemiol 1977;106:203-14.
31. Geisser ME, Roth RS, Robinson ME. Assessing depression among persons with chronic pain using the Center for Epidemiology Studies-Depression Scale and the Beck Depression Inventory: A comparative analysis. Clin J Pain 1997;13:163-70.
32. Radloff LS, Locke BZ. The Community Mental Health Assessment Survey and the CES-D Scale. In: Weissman M, Myers J, Ross C, eds. Community Surveys. Piscataway, NJ: Rutgers University Press; 1977: 177-89.
33. Rosenstiel AK, Keefe FJ. The use of coping strategies in chronic low back pain patients: Relationship to patient characteristic and current adjustment. Pain 1983;17:33-44.
34. Sullivan MJ, Thorn B, Hayethornthwaite JA, et al. Theoretical perspectives on the relation between catastrophizing and pain. Clin J Pain 2001;17:52-64.
35. Stewart MW, Harvey ST, Evan IM. Coping and catastrophizing in chronic pain: A psychometric analysis and comparison of two measures. Clin J Psychol 2001;57:131-8.
36. Smith C, Cowan C, Heffler S, Catlin A, and the National Health Accounts Team. National health spending in 2004: Recent slowdown led by prescription drug spending. Health Aff 2006; 25: 186-96.
37. Hoffman J, Barefield FA, Ramamurthy S. A survey of physician knowledge of drug costs. J Pain Symptom Manage 1995;10:432-5.
38. Reichert S, Simon T, Halm EA. Physicians' attitudes about prescribing and knowledge of the costs of common medications. Arch Intern Med 2000;160:2799-803.
39. Caudill M, Schnable R, Zuttermeister P, Benson H, Friedman R. Decreased clinic use by chronic pain patients: Response to behavioral medicine intervention. Clin J Pain 1991;7:305-10.
40. Mayer TG, Gatchel RJ, Mayer H, et al. Prospective two year study of functional restoration in industrial low back injury. JAMA 1987;258:1763-7.
41. Simmons JW, Avant WS, Jr, Demski J, Parisher D. Determining successful pain clinic treatment through validation of cost effectiveness. Spine 1988;13:342-4.
42. Flor H, Fydrich T, Turk DC. Efficacy of multidisciplinary pain treatment centers: A meta-analytic review. Pain 1992;49:221-30.
43. Hooten WM, Townsend CO, Sletten CD, Bruce BK, Rome JD. Treatment outcomes after multidisciplinary pain rehabilitation with analgesic medication withdrawal for patients with fibromyalgia. Pain Med 2007;8:8-16.
44. Crook J, Tunks E, Rideout E, Browne G. Epidemiologic comparison of persistent pain sufferers in a specialty pain clinic and in the community. Arch Phys Med Rehabil 1986;67:451-5.